Healthcare Data Monetization Market - Global Forecast To 2030
商品番号 : SMB-36063
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年6月 |
| ページ数 | 334 |
| 図表数 | 329 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、ヘルスケアデータ収益化市場を分析しています。市場規模と将来の成長ポテンシャルを、市場の種類、導入形態、エンドユーザー、地域に基づいて様々な市場セグメントごとに推定することを目的としています。また、主要プレーヤーの競合分析に加え、企業概要、製品ラインナップ、最近の動向、主要な市場戦略についても解説しています。
The global healthcare data monetization market is projected to reach USD 1.16 billion by 2030 from USD 0.58 billion in 2025, at a CAGR of 14.9% during the forecast period. The growth of the market is mainly driven by the increasing volume of medical imaging data, the shift towards enterprise-wide interoperability, and the rising demand for centralized, vendor-neutral platforms that streamline imaging workflows. Additionally, healthcare digitization initiatives and regulatory support for health information exchange are further promoting market expansion. However, high implementation costs and challenges related to data migration continue to hinder the adoption of advanced Vendor Neutral Archives (VNA) and Picture Archiving and Communication Systems (PACS) solutions, particularly among small and mid-sized healthcare providers.
世界の医療データ収益化市場は、2025年の5億8,000万米ドルから2030年には11億6,000万米ドルに達し、予測期間中に年平均成長率（CAGR）14.9%で成長すると予測されています。市場の成長は、主に医療画像データ量の増加、企業全体の相互運用性への移行、そして画像処理ワークフローを効率化する集中型ベンダー中立プラットフォームへの需要の高まりによって牽引されています。さらに、医療デジタル化の取り組みと医療情報交換に対する規制当局の支援も、市場拡大をさらに促進しています。しかしながら、導入コストの高さとデータ移行に伴う課題が、特に中小規模の医療提供者において、高度なベンダー中立型アーカイブ（VNA）および画像アーカイブ・コミュニケーションシステム（PACS）ソリューションの導入を阻む要因となっています。
“Services, an indirect data monetization segment, will witness the highest growth during the forecast period.”
Based on type, the healthcare data monetization market is segmented into direct and indirect data monetization. The direct data monetization segment is divided into software and services. Similarly, the indirect data monetization market is also categorized into software and services. Among these, the services subsegment of indirect data monetization is expected to experience the fastest growth during the forecast period. This growth is driven by the increasing demand for specialized expertise in extracting actionable insights from complex health data. As the focus on advanced analytics, interoperability, and real-world evidence continues to rise, service providers are assisting healthcare organizations in unlocking monetization potential without directly selling data. Companies such as Innovaccer, Komodo Health, and IQVIA offer platforms and consulting services that enable data integration, predictive modeling, and strategic collaborations. These efforts help drive revenue through value-based care, research, and product innovation.
“The on-premise segment held the largest segment in the healthcare data monetization market, by deployment model, in 2024.”
By deployment model, the on-premise deployment model held the largest share of the healthcare data monetization market in 2024, primarily due to its advantages in data security, control, and compliance. Healthcare organizations handle highly sensitive patient information and must comply with strict regulatory requirements such as HIPAA, GDPR, and national data protection laws. On-premises systems allow these institutions to maintain direct control over their data infrastructure, which enhances protection against breaches and unauthorized access. Many large hospitals and healthcare providers also have legacy systems and IT investments that work more effectively with on-premises solutions, enabling better integration, customization, and performance optimization. This deployment model is especially preferred in regions with strict data residency laws or limited cloud infrastructure, contributing to its significant market share.
“The Asia Pacific market is expected to register the highest growth throughout the forecast period.”
The Asia Pacific (APAC) region is expected to achieve the highest CAGR in the global healthcare data monetization market during the forecast period. This growth is driven by strong digital health initiatives and the expansion of cloud infrastructure. Initiatives like India’s Ayushman Bharat Digital Mission and China’s Health Information Platform generate large volumes of health data that are well-suited for monetization. Additionally, global technology companies are enhancing regional capabilities, as seen in Microsoft’s USD 2.2 billion investment in Malaysia and Fujitsu’s cloud-based platform in Japan. These developments create a robust foundation for efficient, compliant, and value-driven healthcare data monetization.
The breakdown of primary participants is as mentioned below:
- By Company Type: Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
- By Designation: C-level: 42%, Director-level: 31%, and Others: 27%
- By Region: North America: 35%, Europe: 30%, Asia Pacific: 25%, Middle East & Africa: 5%, Latin America: 5%
Key Players in the Healthcare Data Monetization Market
The key players functioning in the healthcare data monetization market include Oracle Corporation (US), Microsoft Corporation (US), Google (US), Salesforce, Inc. (US), SAS Institute Inc. (US), SAP SE (Germany), TIBCO Software Inc. (US), Sisense Inc. (US), Snowflake Inc. (US), QlikTech International AB (US), HealthVerity, Inc. (US), Accenture (Ireland), Availity, LLC (US), Domo, Inc. (US), Komodo Health, Inc. (US), ThoughtSpot Inc. (US), Datavant (US), Verato (US), Infor, Inc. (US), Virtusa (US), Infosys (India), Particle Health, Inc. (US), Innovaccer, Inc. (US), H1 (US), and Medable Inc. (US).
Research Coverage:
The report analyzes the healthcare data monetization market. It aims to estimate the market size and future growth potential of various market segments based on type, deployment type, end-user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will help established firms and new entrants/smaller firms gauge the market’s pulse, which would help them garner a greater market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their positions in the market.
This report provides insights on:
- Analysis of key drivers (rising volume of healthcare data, shift toward value-based care, advancements in AI and analytics), restraints (data privacy and regulatory concerns, lack of standardization and interoperability), opportunities (emergence of cloud-based data platforms, growing demand for real-world evidence (RWE)), and challenges (ethical concerns around data ownership and consent, limited digital maturity among healthcare providers) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare data monetization market.
- Market Development: Comprehensive information on the lucrative emerging markets, type, deployment, end user, and region.
- Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the healthcare data monetization market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the healthcare data monetization market like Oracle Corporation (US), Microsoft Corporation (US), Google (US), Salesforce (US), SAS Institute (US), and SAP (Germany).
Table of Contents
1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.3 INCLUSIONS AND EXCLUSIONS 30
1.4 MARKET SCOPE 31
1.4.1 MARKET SEGMENTATION 31
1.5 YEARS CONSIDERED 32
1.6 CURRENCY CONSIDERED 32
1.7 LIMITATIONS 33
1.8 STAKEHOLDERS 33
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
2.2 RESEARCH APPROACH 36
2.2.1 SECONDARY RESEARCH 36
2.2.1.1 Key data from secondary sources 37
2.2.2 PRIMARY RESEARCH 37
2.2.2.1 Key primary sources 38
2.2.2.2 Key data from primary sources 39
2.2.2.3 Key industry insights 39
2.2.2.4 Breakdown of primary interviews 40
2.3 RESEARCH METHODOLOGY DESIGN 40
2.4 MARKET SIZE ESTIMATION 41
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 47
2.6 RESEARCH ASSUMPTIONS 48
2.7 RISK ASSESSMENT 49
2.8 RESEARCH LIMITATIONS 50
2.8.1 METHODOLOGY-RELATED LIMITATIONS 50
2.8.2 SCOPE-RELATED LIMITATIONS 50
3 EXECUTIVE SUMMARY 51
4 PREMIUM INSIGHTS 55
4.1 OPPORTUNITIES IN HEALTHCARE DATA MONETIZATION MARKET 55
4.2 HEALTHCARE DATA MONETIZATION MARKET, BY REGION 56
4.3 HEALTHCARE DATA MONETIZATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 56
4.4 HEALTHCARE DATA MONETIZATION MARKET IN NORTH AMERICA, BY END USER
AND COUNTRY 57
4.5 HEALTHCARE DATA MONETIZATION MARKET: DEVELOPED VS. EMERGING MARKETS 58
5 MARKET OVERVIEW 59
5.1 INTRODUCTION 59
5.2 MARKET DYNAMICS 59
5.2.1 DRIVERS 60
5.2.1.1 Growing use of external data sources 60
5.2.1.2 Increasing adoption of electronic health records (EHRs) 61
5.2.1.3 Growing volume of large and complex healthcare datasets 61
5.2.1.4 Rising need to curtail escalating healthcare costs 62
5.2.2 RESTRAINTS 64
5.2.2.1 Lack of data standardization and interoperability 64
5.2.2.2 Regulatory constraints 65
5.2.3 OPPORTUNITIES 66
5.2.3.1 Rising demand for real-world evidence 66
5.2.3.2 Emergence of personalized medicine and genomics 67
5.2.4 CHALLENGES 68
5.2.4.1 Security concerns 68
5.3 INDUSTRY TRENDS 71
5.3.1 HIGH DEMAND FOR OUTCOME-LINKED DATA MONETIZATION DUE TO SURGE IN VALUE-BASED CARE 71
5.3.2 SIGNIFICANT DEMAND FOR REAL-WORLD DATA (RWD) BY PHARMA COMPANIES FOR DRUG DEVELOPMENT 72
5.3.3 EMERGENCE OF HEALTH DATA MARKETPLACES FOR DATA EXCHANGE 72
5.3.4 GROWTH IN CONSUMER-GENERATED HEALTH DATA 73
5.4 TYPES OF HEALTHCARE DATA MONETIZATION SOLUTIONS 73
5.4.1 DIRECT DATA MONETIZATION 74
5.4.2 INDIRECT DATA MONETIZATION 74
5.5 TECHNOLOGY ANALYSIS 75
5.5.1 DATA AS A SERVICE 75
5.5.2 INSIGHT AS A SERVICE 75
5.5.3 ANALYTICS-ENABLED PLATFORM AS A SERVICE 75
5.5.4 EMBEDDED ANALYTICS 75
5.5.5 ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML) 76
5.6 REGULATORY LANDSCAPE 76
5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS 76
5.6.2 REGULATIONS 77
5.7 SUPPLY CHAIN ANALYSIS 79
5.8 ECOSYSTEM ANALYSIS 81
5.9 PATENT ANALYSIS 82
5.9.1 PATENT PUBLICATION TRENDS IN HEALTHCARE DATA MONETIZATION MARKET 82
5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS 82
5.10 CASE STUDY ANALYSIS 87
5.10.1 CASE STUDY 1: ACCOLADE REDUCES PATIENT ONBOARDING TIME BY DEPLOYING AWS-INTEGRATED DATA FABRIC SOLUTION 87
5.10.2 CASE STUDY 2: LEADING HEALTHCARE REVENUE MANAGEMENT COMPANY ADOPTS TIBCO SOFTWARE TO CUT DEVELOPER COSTS BY 50% 87
5.10.3 CASE STUDY 3: SAKURA FINETEK EUROPE FUTURE-PROOFS ITS BUSINESS BY DEPLOYING ORACLE CLOUD APPLICATIONS 88
5.10.4 CASE STUDY 4: AMERISOURCEBERGEN GAINS FINANCE EFFICIENCIES USING ORACLE CLOUD EPM 89
5.10.5 CASE STUDY 5: SKYGEN IMPROVES FINANCIAL VISIBILITY USING ORACLE CLOUD ERP AND EPM 90
5.10.6 CASE STUDY 6: HEALTH FIRST USES AZURE SYNAPSE ANALYTICS TO CREATE A DATA MANAGEMENT SOLUTION AND IMPROVE REFRESH SPEEDS BY 75% 91
5.10.7 CASE STUDY 7: COMMERCIAL UNDERWRITER ADOPTS HEALTHVERITY’S HVID SOLUTION TO CALIBRATE RISKS IN INSURANCE POLICIES 92
5.10.8 CASE STUDY 8: PHARMA COMPANIES USE HEALTHVERITY’S HVID SOLUTION IN PRAGMATIC CLINICAL TRIALS TO TRACK TREATMENT AND CLINICALLY RELEVANT OUTCOMES 92
5.10.9 CASE STUDY 9: PHARMA COMPANIES ADOPT HEALTHVERITY’S HVID SOLUTION TO IDENTIFY HEART FAILURE PATIENTS 93
5.10.10 CASE STUDY 10: PHARMA COMPANIES DEPLOY HEALTHVERITY MARKETPLACE AND CENSUS SOLUTIONS FOR CLINICAL TRIAL ANALYSIS 93
5.11 PORTER’S FIVE FORCES ANALYSIS 94
5.11.1 THREAT OF NEW ENTRANTS 95
5.11.2 THREAT OF SUBSTITUTES 95
5.11.3 BARGAINING POWER OF SUPPLIERS 95
5.11.4 BARGAINING POWER OF BUYERS 95
5.11.5 INTENSITY OF COMPETITIVE RIVALRY 96
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 96
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 96
5.12.2 BUYING CRITERIA 97
5.13 KEY CONFERENCES AND EVENTS, 2025 98
5.14 AVERAGE SELLING PRICE: DATA MONETIZATION MARKET 98
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 102
6 IMPACT OF 2025 US TARIFF ON HEATHCARE DATA MONETIZATION MARKET 104
6.1 INTRODUCTION 104
6.2 KEY TARIFF RATES 105
6.3 PRICE IMPACT ANALYSIS 105
6.4 IMPACT ON COUNTRY/REGION 106
6.4.1 US 106
6.4.2 EUROPE 106
6.4.3 ASIA PACIFIC 107
6.5 IMPACT ON END USERS 108
6.5.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 108
6.5.1.1 Clinical trial data analytics 108
6.5.1.2 Real-world evidence platforms 108
6.5.1.3 Genomics and precision medicines 108
6.5.1.4 Supply chain data analytics 109
6.5.1.5 Regulatory compliance 109
6.5.2 HEALTHCARE PAYERS 109
6.5.2.1 Claims analytics platforms 109
6.5.2.2 Population health management 109
6.5.2.3 Risk assessment and underwriting 109
6.5.2.4 Regulatory reporting 109
6.5.2.5 Market consolidation 109
6.5.3 HEALTHCARE SERVICE PROVIDERS 109
6.5.3.1 Clinical decision support 110
6.5.3.2 Operational analytics 110
6.5.3.3 Research and clinical trials 110
6.5.3.4 Benchmarking and comparative analytics 110
6.5.3.5 Technology integration 110
6.5.4 MEDTECH COMPANIES 110
6.5.4.1 Product development analytics 110
6.5.4.2 Post-market surveillance 110
6.5.4.3 Device data monetization 110
6.5.4.4 Regulatory compliance 111
6.5.4.5 Supply chain integration 111
6.5.5 DIGITAL HEALTH COMPANIES 111
6.5.6 HEALTHCARE CONSULTING FIRMS 111
6.5.7 ACADEMIC RESEARCH INSTITUTIONS 111
6.5.8 GOVERNMENT AGENCIES 111
7 HEALTHCARE DATA MONETIZATION MARKET, BY TYPE 112
7.1 INTRODUCTION 113
7.2 DIRECT DATA MONETIZATION 114
7.2.1 SOFTWARE 116
7.2.1.1 Rising adoption of AI, ML, and blockchain technologies to enhance value proposition of data assets to drive market 116
7.2.2 SERVICES 117
7.2.2.1 Cloud-based infrastructure, scalability, and cost-effectiveness to improve adoption of direct data monetization services 117
7.3 INDIRECT DATA MONETIZATION 118
7.3.1 SOFTWARE 119
7.3.1.1 Growing focus on data analytics and insights to support market growth 119
7.3.2 SERVICES 121
7.3.2.1 Rising emphasis on advanced data analytics and actionable insights to contribute to market growth 121
8 HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE 123
8.1 INTRODUCTION 124
8.1.1 CLINICAL DATA 124
8.1.1.1 Rising use of AI and ML to extract actionable insights from clinical data to create opportunities 124
8.1.2 CLINICAL TRIAL DATA 125
8.1.2.1 Growing demand for real-world evidence and AI-driven trial optimization to drive market 125
8.1.3 CLAIMS AND BILLING DATA 126
8.1.3.1 Surging requirement for value-based care and cost transparency to boost segmental growth 126
8.1.4 CONSUMER AND DIGITAL HEALTH DATA 126
8.1.4.1 Elevating demand for chronic disease management and predictive healthcare services to support market growth 126
8.1.5 GENOMIC AND MOLECULAR DATA 127
8.1.5.1 Rising preference for precision and personalized medicines to foster market growth 127
8.1.6 OTHER DATA TYPES 128
9 HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT 129
9.1 INTRODUCTION 130
9.2 ON-PREMISES 130
9.2.1 EMPHASIS ON MINIMIZING DATA EXPOSURE TO THIRD-PARTY ENVIRONMENTS TO BOOST SEGMENTAL GROWTH 130
9.3 CLOUD-BASED 131
9.3.1 FOCUS ON OPTIMIZING DEPLOYMENT COSTS TO FUEL SEGMENTAL GROWTH 131
10 HEALTHCARE DATA MONETIZATION MARKET, BY END USER 133
10.1 INTRODUCTION 134
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 134
10.2.1 RISING USE OF RWD AND RWE TO ACCELERATE MARKET GROWTH 134
10.3 HEALTHCARE PAYERS 135
10.3.1 PRESSING NEED TO DESIGN INNOVATIVE VALUE-BASED CARE MODELS TO CREATE OPPORTUNITIES 135
10.4 HEALTHCARE PROVIDERS 136
10.4.1 URGENT REQUIREMENT TO OPTIMIZE CLINICAL WORKFLOWS AND IDENTIFY HIGH-RISK POPULATIONS TO BOOST MARKET GROWTH 136
10.5 MEDICAL TECHNOLOGY COMPANIES 137
10.5.1 INCREASING PENETRATION OF CONNECTED MEDICAL DEVICES AND WEARABLES TO PROPEL MARKET 137
10.6 OTHER END USERS 138
11 HEALTHCARE DATA MONETIZATION MARKET, BY REGION 139
11.1 INTRODUCTION 140
11.2 NORTH AMERICA 140
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 141
11.2.2 US 144
11.2.2.1 Inclination toward value-based care and outcome-focused healthcare models to stimulate demand 144
11.2.3 CANADA 147
11.2.3.1 Growing digitization of healthcare records to boost adoption 147
11.3 EUROPE 150
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 150
11.3.2 UK 153
11.3.2.1 Growing use of wearable medical devices to fuel market growth 153
11.3.3 GERMANY 155
11.3.3.1 Government initiatives to develop digital healthcare ecosystem to create opportunities 155
11.3.4 FRANCE 158
11.3.4.1 Government initiatives promoting digital health roadmap to boost demand 158
11.3.5 ITALY 160
11.3.5.1 Focus of healthcare sector on digital transformation to support market growth 160
11.3.6 SPAIN 163
11.3.6.1 Surging demand for predictive analytics and value-based care models to fuel market growth 163
11.3.7 REST OF EUROPE 165
11.4 ASIA PACIFIC 168
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 168
11.4.2 JAPAN 172
11.4.2.1 Elevating need for effective patient management solutions with increasing geriatric population to drive market 172
11.4.3 CHINA 175
11.4.3.1 High prevalence of chronic diseases to drive demand 175
11.4.4 INDIA 177
11.4.4.1 Government initiatives to create unified digital health ecosystem to foster market growth 177
11.4.5 REST OF ASIA PACIFIC 180
11.5 LATIN AMERICA 182
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 183
11.5.2 BRAZIL 185
11.5.2.1 Government initiatives to digitize patient records to boost demand 185
11.5.3 MEXICO 188
11.5.3.1 Rising adoption of telemedicine and mobile health platforms to drive market 188
11.5.4 REST OF LATIN AMERICA 190
11.6 MIDDLE EAST & AFRICA 192
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 193
11.6.2 GCC 195
11.6.2.1 National digital health visions and AI-driven healthcare transformation to propel market 195
11.6.3 REST OF MIDDLE EAST & AFRICA 198
12 COMPETITIVE LANDSCAPE 201
12.1 OVERVIEW 201
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025 201
12.3 REVENUE ANALYSIS, 2020–2024 204
12.4 MARKET SHARE ANALYSIS, 2024 206
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 208
12.5.1 STARS 208
12.5.2 EMERGING LEADERS 208
12.5.3 PERVASIVE PLAYERS 208
12.5.4 PARTICIPANTS 208
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 210
12.5.5.1 Company footprint 210
12.5.5.2 Region footprint 211
12.5.5.3 Type footprint 212
12.5.5.4 End user footprint 213
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 214
12.6.1 PROGRESSIVE COMPANIES 214
12.6.2 RESPONSIVE COMPANIES 214
12.6.3 DYNAMIC COMPANIES 214
12.6.4 STARTING BLOCKS 214
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 216
12.6.5.1 Detailed list of key startups/SMEs 216
12.6.5.2 Competitive benchmarking of key startups/SMEs 217
12.7 COMPANY VALUATION AND FINANCIAL METRICS 218
12.7.1 FINANCIAL METRICS 218
12.7.2 COMPANY VALUATION 218
12.8 BRAND/SOFTWARE COMPARISON 219
12.9 COMPETITIVE SCENARIO 219
12.9.1 PRODUCT LAUNCHES & ENHANCEMENTS 219
12.9.2 DEALS 221
13 COMPANY PROFILES 222
13.1 KEY PLAYERS 222
13.1.1 ORACLE 222
13.1.1.1 Business overview 222
13.1.1.2 Products offered 224
13.1.1.3 Recent developments 225
13.1.1.3.1 Product launches & enhancements 225
13.1.1.3.2 Deals 227
13.1.1.4 MnM view 229
13.1.1.4.1 Right to win 229
13.1.1.4.2 Strategic choices 229
13.1.1.4.3 Weaknesses & competitive threats 229
13.1.2 MICROSOFT 230
13.1.2.1 Business overview 230
13.1.2.2 Products offered 231
13.1.2.3 Recent developments 232
13.1.2.3.1 Product launches & enhancements 232
13.1.2.3.2 Deals 234
13.1.2.4 MnM view 235
13.1.2.4.1 Right to win 235
13.1.2.4.2 Strategic choices 236
13.1.2.4.3 Weaknesses & competitive threats 236
13.1.3 GOOGLE 237
13.1.3.1 Business overview 237
13.1.3.2 Products offered 238
13.1.3.3 Recent developments 239
13.1.3.3.1 Product launches & enhancements 239
13.1.3.3.2 Deals 241
13.1.3.4 MnM view 243
13.1.3.4.1 Right to win 243
13.1.3.4.2 Strategic choices 243
13.1.3.4.3 Weaknesses & competitive threats 243
13.1.4 SALESFORCE, INC. 244
13.1.4.1 Business overview 244
13.1.4.2 Products offered 245
13.1.4.3 Recent developments 247
13.1.4.3.1 Product launches & enhancements 247
13.1.4.3.2 Deals 249
13.1.4.4 MnM view 250
13.1.4.4.1 Right to win 250
13.1.4.4.2 Strategic choices 250
13.1.4.4.3 Weaknesses & competitive threats 250
13.1.5 SAS INSTITUTE INC. 251
13.1.5.1 Business overview 251
13.1.5.2 Products offered 252
13.1.5.3 Recent developments 253
13.1.5.3.1 Product launches & enhancements 253
13.1.5.3.2 Deals 254
13.1.5.4 MnM view 255
13.1.5.4.1 Right to win 255
13.1.5.4.2 Strategic choices 255
13.1.5.4.3 Weaknesses & competitive threats 255
13.1.6 SAP SE 256
13.1.6.1 Business overview 256
13.1.6.2 Products offered 257
13.1.6.3 Recent developments 259
13.1.6.3.1 Product launches & enhancements 259
13.1.6.3.2 Deals 261
13.1.7 TIBCO SOFTWARE INC. 263
13.1.7.1 Business overview 263
13.1.7.2 Products offered 263
13.1.7.3 Recent developments 264
13.1.7.3.1 Product launches & enhancements 264
13.1.7.3.2 Deals 266
13.1.8 SNOWFLAKE INC. 267
13.1.8.1 Business overview 267
13.1.8.2 Products offered 268
13.1.8.3 Recent developments 269
13.1.8.3.1 Product launches & enhancements 269
13.1.8.3.2 Deals 270
13.1.9 QLIKTECH INTERNATIONAL AB 272
13.1.9.1 Business overview 272
13.1.9.2 Products offered 272
13.1.9.3 Recent developments 273
13.1.9.3.1 Product launches & enhancements 273
13.1.9.3.2 Deals 274
13.1.10 INFOSYS LIMITED 276
13.1.10.1 Business overview 276
13.1.10.2 Products offered 277
13.1.10.3 Recent developments 279
13.1.10.3.1 Deals 279
13.1.11 SISENSE INC. 280
13.1.11.1 Business overview 280
13.1.11.2 Products offered 280
13.1.11.3 Recent developments 281
13.1.11.3.1 Product launches & enhancements 281
13.1.11.3.2 Deals 281
13.1.12 ACCENTURE 282
13.1.12.1 Business overview 282
13.1.12.2 Products offered 283
13.1.12.3 Recent developments 284
13.1.12.3.1 Product launches & enhancements 284
13.1.12.3.2 Deals 285
13.1.13 AVAILITY, LLC 287
13.1.13.1 Business overview 287
13.1.13.2 Products offered 287
13.1.13.3 Recent developments 288
13.1.13.3.1 Product launches & enhancements 288
13.1.13.3.2 Deals 289
13.1.14 DOMO, INC. 291
13.1.14.1 Business overview 291
13.1.14.2 Products offered 293
13.1.14.3 Recent developments 293
13.1.14.3.1 Product launches & enhancements 293
13.1.14.3.2 Deals 296
13.1.15 KOMODO HEALTH, INC. 297
13.1.15.1 Business overview 297
13.1.15.2 Products offered 297
13.1.15.3 Recent developments 298
13.1.15.3.1 Product launches & enhancements 298
13.1.15.3.2 Deals 299
13.1.16 VIRTUSA 301
13.1.16.1 Business overview 301
13.1.16.2 Products offered 301
13.1.16.3 Recent developments 302
13.1.16.3.1 Product launches & enhancements 302
13.1.16.3.2 Deals 302
13.1.17 DATAVANT 304
13.1.17.1 Business overview 304
13.1.17.2 Products offered 304
13.1.17.3 Recent developments 305
13.1.17.3.1 Product launches & enhancements 305
13.1.17.3.2 Deals 306
13.1.18 INFOR, INC. 310
13.1.18.1 Business overview 310
13.1.18.2 Products offered 310
13.1.18.3 Recent developments 311
13.1.18.3.1 Product launches & enhancements 311
13.1.19 HEALTHVERITY, INC. 312
13.1.19.1 Business overview 312
13.1.19.2 Products offered 312
13.1.19.3 Recent developments 313
13.1.19.3.1 Product launches & enhancements 313
13.1.19.3.2 Deals 314
13.1.20 THOUGHTSPOT INC. 316
13.1.20.1 Business overview 316
13.1.20.2 Products offered 316
13.1.20.3 Recent developments 317
13.1.20.3.1 Product launches & enhancements 317
13.1.20.3.2 Deals 318
13.2 OTHER PLAYERS 318
13.2.1 VERATO 318
13.2.2 PARTICLE HEALTH, INC. 319
13.2.3 INNOVACCER, INC. 320
13.2.4 H1 321
13.2.5 MEDABLE INC. 322
14 APPENDIX 323
14.1 DISCUSSION GUIDE 323
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 329
14.3 CUSTOMIZATION OPTIONS 331
14.4 RELATED REPORTS 332
14.5 AUTHOR DETAILS 333
LIST OF TABLES
TABLE 1 EXCHANGE RATES CONSIDERED FOR CONVERSION TO USD 32
TABLE 2 FACTOR ANALYSIS 45
TABLE 3 ASSUMPTIONS FOR RESEARCH STUDY 48
TABLE 4 LIMITATIONS AND ASSOCIATED RISKS 49
TABLE 5 MAJOR HEALTHCARE DATA BREACHES (2021–2025) 69
TABLE 6 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT
AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 7 NORTH AMERICA: REGULATIONS 77
TABLE 8 EUROPE: REGULATIONS 78
TABLE 9 ASIA PACIFIC: REGULATIONS 78
TABLE 10 MIDDLE EAST & SOUTH AFRICA: REGULATIONS 79
TABLE 11 LATIN AMERICA: REGULATIONS 79
TABLE 12 HEALTHCARE DATA MONETIZATION MARKET: LIST OF PATENTS/PATENT APPLICATIONS, 2022–2025 84
TABLE 13 HEALTHCARE DATA MONETIZATION MARKET: PORTER’S FIVE FORCES ANALYSIS 94
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 96
TABLE 15 KEY BUYING CRITERIA, BY END USER (%) 97
TABLE 16 HEALTHCARE DATA MONETIZATION MARKET: DETAILED LIST OF
CONFERENCES AND EVENTS 98
TABLE 17 COMMONLY ADOPTED PRICING STRATEGIES IN HEALTHCARE
DATA MONETIZATION MARKET 98
TABLE 18 MICROSOFT CORPORATION: PRICING OF AZURE HEALTH DATA SERVICES 99
TABLE 19 MICROSOFT CORPORATION: PRICING OF AZURE API FOR FHIR 99
TABLE 20 MICROSOFT CORPORATION: PRICING OF AZURE DATA SHARE 100
TABLE 21 MICROSOFT CORPORATION: PRICING OF MEDIA SERVICES 100
TABLE 22 SALESFORCE, INC.: PRICING OF HEALTH CLOUD 100
TABLE 23 SALESFORCE, INC.: PRICING OF DATA CLOUD FOR HEALTH 101
TABLE 24 SALESFORCE, INC.: PRICING OF ADDITIONAL SOLUTIONS 101
TABLE 25 US-ADJUSTED RECIPROCAL TARIFF RATES 105
TABLE 26 HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 113
TABLE 27 HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 115
TABLE 28 DIRECT DATA MONETIZATION: HEALTHCARE DATA MONETIZATION MARKET,
BY REGION, 2023–2030 (USD MILLION) 115
TABLE 29 DIRECT DATA MONETIZATION: HEALTHCARE DATA MONETIZATION MARKET
FOR SOFTWARE, BY REGION, 2023–2030 (USD MILLION) 117
TABLE 30 DIRECT DATA MONETIZATION: HEALTHCARE DATA MONETIZATION MARKET
FOR SERVICES, BY REGION, 2023–2030 (USD MILLION) 118
TABLE 31 HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 119
TABLE 32 INDIRECT DATA MONETIZATION: HEALTHCARE DATA MONETIZATION MARKET,
BY REGION, 2023–2030 (USD MILLION) 119
TABLE 33 INDIRECT DATA MONETIZATION: HEALTHCARE DATA MONETIZATION MARKET
FOR SOFTWARE, BY REGION, 2023–2030 (USD MILLION) 121
TABLE 34 INDIRECT DATA MONETIZATION: HEALTHCARE DATA MONETIZATION MARKET FOR SERVICES, BY REGION, 2023–2030 (USD MILLION) 122
TABLE 35 HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE,
2023–2030 (USD MILLION) 124
TABLE 36 CLINICAL DATA: HEALTHCARE DATA MONETIZATION MARKET,
BY REGION, 2023–2030 (USD MILLION) 125
TABLE 37 CLINICAL TRIAL DATA: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 125
TABLE 38 CLAIMS AND BILLING DATA: HEALTHCARE DATA MONETIZATION MARKET,
BY REGION, 2023–2030 (USD MILLION) 126
TABLE 39 CONSUMER AND DIGITAL HEALTH DATA: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 127
TABLE 40 GENOMIC AND MOLECULAR DATA: HEALTHCARE DATA MONETIZATION MARKET,
BY REGION, 2023–2030 (USD MILLION) 128
TABLE 41 OTHER DATA TYPES: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 128
TABLE 42 HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT,
2023–2030 (USD MILLION) 130
TABLE 43 ON-PREMISES: HEALTHCARE DATA MONETIZATION MARKET, BY REGION,
2023–2030 (USD MILLION) 131
TABLE 44 CLOUD-BASED: HEALTHCARE DATA MONETIZATION MARKET, BY REGION,
2023–2030 (USD MILLION) 132
TABLE 45 HEALTHCARE DATA MONETIZATION MARKET, BY END USER,
2023–2030 (USD MILLION) 134
TABLE 46 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 135
TABLE 47 HEALTHCARE PAYERS: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 136
TABLE 48 HEALTHCARE PROVIDERS: HEALTHCARE DATA MONETIZATION MARKET,
BY REGION, 2023–2030 (USD MILLION) 137
TABLE 49 MEDICAL TECHNOLOGY COMPANIES: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 137
TABLE 50 OTHER END USERS: HEALTHCARE DATA MONETIZATION MARKET,
BY REGION, 2023–2030 (USD MILLION) 138
TABLE 51 HEALTHCARE DATA MONETIZATION MARKET, BY REGION,
2023–2030 (USD MILLION) 140
TABLE 52 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 53 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 143
TABLE 54 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING 2023–2030 (USD MILLION) 143
TABLE 55 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 143
TABLE 56 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 143
TABLE 57 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 144
TABLE 58 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 144
TABLE 59 US: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 145
TABLE 60 US: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 145
TABLE 61 US: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 146
TABLE 62 US: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT,
2023–2030 (USD MILLION) 146
TABLE 63 US: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE,
2023–2030 (USD MILLION) 146
TABLE 64 US: HEALTHCARE DATA MONETIZATION MARKET, BY END USER,
2023–2030 (USD MILLION) 147
TABLE 65 CANADA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 148
TABLE 66 CANADA: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 148
TABLE 67 CANADA: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING 2023–2030 (USD MILLION) 148
TABLE 68 CANADA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT,
2023–2030 (USD MILLION) 149
TABLE 69 CANADA: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE,
2023–2030 (USD MILLION) 149
TABLE 70 CANADA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER,
2023–2030 (USD MILLION) 149
TABLE 71 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 151
TABLE 72 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 151
TABLE 73 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 151
TABLE 74 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 152
TABLE 75 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT,
2023–2030 (USD MILLION) 152
TABLE 76 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE,
2023–2030 (USD MILLION) 152
TABLE 77 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY END USER,
2023–2030 (USD MILLION) 153
TABLE 78 UK: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 154
TABLE 79 UK: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 154
TABLE 80 UK: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 154
TABLE 81 UK: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT,
2023–2030 (USD MILLION) 154
TABLE 82 UK: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE,
2023–2030 (USD MILLION) 155
TABLE 83 UK: HEALTHCARE DATA MONETIZATION MARKET, BY END USER,
2023–2030 (USD MILLION) 155
TABLE 84 GERMANY: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 156
TABLE 85 GERMANY: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 156
TABLE 86 GERMANY: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 157
TABLE 87 GERMANY: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT,
2023–2030 (USD MILLION) 157
TABLE 88 GERMANY: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE,
2023–2030 (USD MILLION) 157
TABLE 89 GERMANY: HEALTHCARE DATA MONETIZATION MARKET, BY END USER,
2023–2030 (USD MILLION) 158
TABLE 90 FRANCE: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 159
TABLE 91 FRANCE: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION TYPE, 2023–2030 (USD MILLION) 159
TABLE 92 FRANCE: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION TYPE, 2023–2030 (USD MILLION) 159
TABLE 93 FRANCE: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT,
2023–2030 (USD MILLION) 159
TABLE 94 FRANCE: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE,
2023–2030 (USD MILLION) 160
TABLE 95 FRANCE: HEALTHCARE DATA MONETIZATION MARKET, BY END USER,
2023–2030 (USD MILLION) 160
TABLE 96 ITALY: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 161
TABLE 97 ITALY: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 161
TABLE 98 ITALY: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 162
TABLE 99 ITALY: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT,
2023–2030 (USD MILLION) 162
TABLE 100 ITALY: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE,
2023–2030 (USD MILLION) 162
TABLE 101 ITALY: HEALTHCARE DATA MONETIZATION MARKET, BY END USER,
2023–2030 (USD MILLION) 163
TABLE 102 SPAIN: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 164
TABLE 103 SPAIN: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 164
TABLE 104 SPAIN: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 164
TABLE 105 SPAIN: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT,
2023–2030 (USD MILLION) 164
TABLE 106 SPAIN: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE,
2023–2030 (USD MILLION) 165
TABLE 107 SPAIN: HEALTHCARE DATA MONETIZATION MARKET, BY END USER,
2023–2030 (USD MILLION) 165
TABLE 108 REST OF EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 166
TABLE 109 REST OF EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 166
TABLE 110 REST OF EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 167
TABLE 111 REST OF EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 167
TABLE 112 REST OF EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 167
TABLE 113 REST OF EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 168
TABLE 114 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 170
TABLE 115 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 170
TABLE 116 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING , 2023–2030 (USD MILLION) 170
TABLE 117 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING , 2023–2030 (USD MILLION) 171
TABLE 118 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 171
TABLE 119 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE,
2023–2030 (USD MILLION) 171
TABLE 120 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY END USER,
2023–2030 (USD MILLION) 172
TABLE 121 JAPAN: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 173
TABLE 122 JAPAN: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING , 2023–2030 (USD MILLION) 173
TABLE 123 JAPAN: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 173
TABLE 124 JAPAN: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT,
2023–2030 (USD MILLION) 174
TABLE 125 JAPAN: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE,
2023–2030 (USD MILLION) 174
TABLE 126 JAPAN: HEALTHCARE DATA MONETIZATION MARKET, BY END USER,
2023–2030 (USD MILLION) 174
TABLE 127 CHINA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 175
TABLE 128 CHINA: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 176
TABLE 129 CHINA: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 176
TABLE 130 CHINA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT,
2023–2030 (USD MILLION) 176
TABLE 131 CHINA: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE,
2023–2030 (USD MILLION) 177
TABLE 132 CHINA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER,
2023–2030 (USD MILLION) 177
TABLE 133 INDIA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 178
TABLE 134 INDIA: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 178
TABLE 135 INDIA: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 178
TABLE 136 INDIA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT,
2023–2030 (USD MILLION) 179
TABLE 137 INDIA: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE,
2023–2030 (USD MILLION) 179
TABLE 138 INDIA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER,
2023–2030 (USD MILLION) 179
TABLE 139 REST OF ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 140 REST OF ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 181
TABLE 141 REST OF ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 181
TABLE 142 REST OF ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET,
BY DEPLOYMENT, 2023–2030 (USD MILLION) 181
TABLE 143 REST OF ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET,
BY DATA TYPE, 2023–2030 (USD MILLION) 182
TABLE 144 REST OF ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 182
TABLE 145 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 183
TABLE 146 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 184
TABLE 147 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 184
TABLE 148 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 184
TABLE 149 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 184
TABLE 150 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 185
TABLE 151 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 185
TABLE 152 BRAZIL: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 186
TABLE 153 BRAZIL: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 186
TABLE 154 BRAZIL: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 186
TABLE 155 BRAZIL: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT,
2023–2030 (USD MILLION) 187
TABLE 156 BRAZIL: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE,
2023–2030 (USD MILLION) 187
TABLE 157 BRAZIL: HEALTHCARE DATA MONETIZATION MARKET, BY END USER,
2023–2030 (USD MILLION) 187
TABLE 158 MEXICO: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 188
TABLE 159 MEXICO: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 188
TABLE 160 MEXICO: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 189
TABLE 161 MEXICO: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT,
2023–2030 (USD MILLION) 189
TABLE 162 MEXICO: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE,
2023–2030 (USD MILLION) 189
TABLE 163 MEXICO: HEALTHCARE DATA MONETIZATION MARKET, BY END USER,
2023–2030 (USD MILLION) 190
TABLE 164 REST OF LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 190
TABLE 165 REST OF LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 191
TABLE 166 REST OF LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET,
BY INDIRECT DATA MONETIZATION TYPE, 2023–2030 (USD MILLION) 191
TABLE 167 REST OF LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET,
BY DEPLOYMENT, 2023–2030 (USD MILLION) 191
TABLE 168 REST OF LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET,
BY DATA TYPE, 2023–2030 (USD MILLION) 192
TABLE 169 REST OF LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 192
TABLE 170 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 193
TABLE 171 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 194
TABLE 172 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 194
TABLE 173 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION TYPE, 2023–2030 (USD MILLION) 194
TABLE 174 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET,
BY DEPLOYMENT, 2023–2030 (USD MILLION) 194
TABLE 175 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET,
BY DATA TYPE, 2023–2030 (USD MILLION) 195
TABLE 176 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 195
TABLE 177 GCC: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE,
2023–2030 (USD MILLION) 196
TABLE 178 GCC: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 196
TABLE 179 GCC: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 196
TABLE 180 GCC: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT,
2023–2030 (USD MILLION) 197
TABLE 181 GCC: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE,
2023–2030 (USD MILLION) 197
TABLE 182 GCC: HEALTHCARE DATA MONETIZATION MARKET, BY END USER,
2023–2030 (USD MILLION) 197
TABLE 183 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET,
BY TYPE, 2023–2030 (USD MILLION) 198
TABLE 184 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET,
BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 198
TABLE 185 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET,
BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 199
TABLE 186 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET,
BY DEPLOYMENT, 2023–2030 (USD MILLION) 199
TABLE 187 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET,
BY DATA TYPE, 2023–2030 (USD MILLION) 199
TABLE 188 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 200
TABLE 189 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE DATA MONETIZATION MARKET, JANUARY 2022–MAY 2025 202
TABLE 190 HEALTHCARE DATA MONETIZATION MARKET: DEGREE OF COMPETITION 207
TABLE 191 HEALTHCARE DATA MONETIZATION MARKET: REGION FOOTPRINT 211
TABLE 192 HEALTHCARE DATA MONETIZATION MARKET: TYPE FOOTPRINT 212
TABLE 193 HEALTHCARE DATA MONETIZATION MARKET: END USER FOOTPRINT 213
TABLE 194 HEALTHCARE DATA MONETIZATION MARKET: DETAILED LIST
OF KEY SMES/STARTUPS 216
TABLE 195 HEALTHCARE DATA MONETIZATION MARKET: COMPETITIVE
BENCHMARKING OF KEY SMES SMES/STARTUPS 217
TABLE 196 HEALTHCARE DATA MONETIZATION MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 220
TABLE 197 HEALTHCARE DATA MONETIZATION MARKET: DEALS, JANUARY 2022–MAY 2025 221
TABLE 198 ORACLE: COMPANY OVERVIEW 222
TABLE 199 ORACLE: PRODUCTS OFFERED 224
TABLE 200 ORACLE: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 225
TABLE 201 ORACLE: DEALS, JANUARY 2022–MAY 2025 227
TABLE 202 MICROSOFT: COMPANY OVERVIEW 230
TABLE 203 MICROSOFT: PRODUCTS OFFERED 231
TABLE 204 MICROSOFT: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 232
TABLE 205 MICROSOFT: DEALS, JANUARY 2022–MAY 2025 234
TABLE 206 GOOGLE: COMPANY OVERVIEW 237
TABLE 207 GOOGLE: PRODUCTS OFFERED 238
TABLE 208 GOOGLE: PRODUCT LAUNCHES & ENHANCEMENTS, ENHANCEMENTS
JANUARY 2021–MAY 2025 239
TABLE 209 GOOGLE: DEALS, JANUARY 2021–MAY 2025 241
TABLE 210 SALESFORCE, INC.: COMPANY OVERVIEW 244
TABLE 211 SALESFORCE INC.: PRODUCTS OFFERED 245
TABLE 212 SALESFORCE INC.: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021–MAY 2025 247
TABLE 213 SALESFORCE INC.: DEALS, JANUARY 2022–MAY 2025 249
TABLE 214 SAS INSTITUTE INC.: COMPANY OVERVIEW 251
TABLE 215 SAS INSTITUTE INC.: PRODUCTS OFFERED 252
TABLE 216 SAS INSTITUTE INC.: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021–MAY 2025 253
TABLE 217 SAS INSTITUTE INC.: DEALS, JANUARY 2021–MAY 2025 254
TABLE 218 SAP SE: COMPANY OVERVIEW 256
TABLE 219 SAP SE: PRODUCTS OFFERED 257
TABLE 220 SAP SE: PRODUCT LAUNCHES & ENHANCEMENTS, ENHANCEMENT
JANUARY 2022–MAY 2025 259
TABLE 221 SAP SE: DEALS, JANUARY 2021–MAY 2025 261
TABLE 222 TIBCO SOFTWARE INC.: COMPANY OVERVIEW 263
TABLE 223 TIBCO SOFTWARE INC.: PRODUCTS OFFERED 263
TABLE 224 TIBCO SOFTWARE INC.: PRODUCT LAUNCHES, APPROVALS, & ENHANCEMENT JANUARY 2022–MAY 2025 264
TABLE 225 TIBCO SOFTWARE INC: DEALS, JANUARY 2022–MAY 2025 266
TABLE 226 SNOWFLAKE INC.: COMPANY OVERVIEW 267
TABLE 227 SNOWFLAKE INC.: PRODUCTS OFFERED 268
TABLE 228 SNOWFLAKE INC.: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2022–MAY 2025 269
TABLE 229 SNOWFLAKE INC.: DEALS, JANUARY 2021–MAY 2025 270
TABLE 230 QLIKTECH INTERNATIONAL AB: COMPANY OVERVIEW 272
TABLE 231 QLIKTECH INTERNATIONAL AB: PRODUCTS OFFERED 272
TABLE 232 QLIKTECH INTERNATIONAL AB: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021–MAY 2025 273
TABLE 233 QLIKTECH INTERNATIONAL AB: DEALS, JANUARY 2021–MAY 2025 274
TABLE 234 INFOSYS LIMITED: COMPANY OVERVIEW 276
TABLE 235 INFOSYS LIMITED: PRODUCTS OFFERED 277
TABLE 236 INFOSYS LIMITED: DEALS, JANUARY 2021–MAY 2025 279
TABLE 237 SISENSE INC.: COMPANY OVERVIEW 280
TABLE 238 SISENSE INC.: PRODUCTS OFFERED 280
TABLE 239 SISENSE INC.: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2022–MAY 2025 281
TABLE 240 SISENSE INC.: DEALS, JANUARY 2022–MAY 2025 281
TABLE 241 ACCENTURE: COMPANY OVERVIEW 282
TABLE 242 ACCENTURE: PRODUCTS OFFERED 283
TABLE 243 ACCENTURE: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021–FEBRUARY 2025 284
TABLE 244 ACCENTURE: DEALS, JANUARY 2022–MAY 2025 285
TABLE 245 AVAILITY, LLC: COMPANY OVERVIEW 287
TABLE 246 AVAILITY, LLC: PRODUCTS OFFERED 287
TABLE 247 ATHENAHEALTH, INC.: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021–MAY 2025 288
TABLE 248 ATHENAHEALTH, INC.: DEALS, JANUARY 2022–MAY 2025 289
TABLE 249 DOMO, INC.: COMPANY OVERVIEW 291
TABLE 250 DOMO, INC.: PRODUCTS OFFERED 293
TABLE 251 DOMO, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–MAY 2025 293
TABLE 252 DOMO, INC.: DEALS, JANUARY 2022–MAY 2025 296
TABLE 253 KOMODO HEALTH, INC.: COMPANY OVERVIEW 297
TABLE 254 KOMODO HEALTH, INC.: PRODUCTS OFFERED 297
TABLE 255 KOMODO HEALTH, INC.: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2022–MAY 2025 298
TABLE 256 KOMODO HEALTH, INC.: DEALS, JANUARY 2021–MAY 2025 299
TABLE 257 VIRTUSA: COMPANY OVERVIEW 301
TABLE 258 VIRTUSA: PRODUCTS OFFERED 301
TABLE 259 VIRTUSA: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–MAY 2025 302
TABLE 260 VIRTUSA: DEALS, JANUARY 2021–MAY 2025 302
TABLE 261 DATAVANT: COMPANY OVERVIEW 304
TABLE 262 DATAVANT: PRODUCTS OFFERED 304
TABLE 263 DATAVANT: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 305
TABLE 264 DATAVANT.: DEALS, JANUARY 2022–MAY 2025 306
TABLE 265 INFOR, INC.: COMPANY OVERVIEW 310
TABLE 266 INFOR, INC.: PRODUCTS OFFERED 310
TABLE 267 INFOR, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 311
TABLE 268 HEALTHVERITY, INC.: COMPANY OVERVIEW 312
TABLE 269 HEALTHVERITY, INC.: PRODUCTS OFFERED 312
TABLE 270 HEALTHVERITY, INC.: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021–MAY 2025 313
TABLE 271 HEALTHVERITY, INC.: DEALS, JANUARY 2021–MAY 2025 314
TABLE 272 THOUGHTSPOT INC.: COMPANY OVERVIEW 316
TABLE 273 THOUGHTSPOT INC.: PRODUCTS OFFERED 316
TABLE 274 THOUGHTSPOT INC.: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021–MAY 2025 317
TABLE 275 THOUGHTSPOT INC.: DEALS, JANUARY 2021–MAY 2025 318
LIST OF FIGURES
FIGURE 1 HEALTHCARE DATA MONETIZATION MARKET: MARKET SEGMENTATION 31
FIGURE 2 RESEARCH DESIGN 35
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 40
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 41
FIGURE 5 APPROACH FOR ASSESSING SUPPLY OF HEALTHCARE
DATA MONETIZATION SOLUTIONS 42
FIGURE 6 BOTTOM-UP APPROACH 43
FIGURE 7 TOP-DOWN APPROACH 43
FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN HEALTHCARE DATA MONETIZATION MARKET 46
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 46
FIGURE 10 DATA TRIANGULATION METHODOLOGY 48
FIGURE 11 DIRECT DATA MONETIZATION SEGMENT TO LEAD MARKET THROUGHOUT FORECAST PERIOD 51
FIGURE 12 CLOUD-BASED HEALTHCARE DATA MONETIZATION MODELS TO EXHIBIT HIGHER CAGR DURING FORECAST PERIOD 52
FIGURE 13 CLINICAL DATA SEGMENT TO LEAD MARKET THROUGHOUT FORECAST PERIOD 52
FIGURE 14 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE HEALTHCARE DATA MONETIZATION MARKET THROUGHOUT FORECAST PERIOD 53
FIGURE 15 NORTH AMERICA HELD LARGEST MARKET SHARE IN 2024 54
FIGURE 16 EXPONENTIALLY INCREASING DATA VOLUMES AND GENERATION OF LARGE AND COMPLEX HEALTHCARE DATASETS TO DRIVE MARKET 55
FIGURE 17 NORTH AMERICA TO CAPTURE MAJORITY OF HEALTHCARE DATA MONETIZATION MARKET SHARE IN 2030 56
FIGURE 18 CHINA TO BE FASTEST-GROWING HEALTHCARE DATA MONETIZATION MARKET GLOBALLY FROM 2025 TO 2030 56
FIGURE 19 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND US DOMINATED MARKET IN NORTH AMERICA IN 2024 57
FIGURE 20 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES
DURING FORECAST PERIOD 58
FIGURE 21 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES:
HEALTHCARE DATA MONETIZATION MARKET 59
FIGURE 22 US: ADOPTION OF ELECTRONIC HEALTH RECORDS, BY HOSPITAL
SERVICE TYPE (2021) 61
FIGURE 23 COST OF GENOME ANALYSIS VS. VOLUME OF RAW DATA GENERATED, 2003–2023 62
FIGURE 24 US HEALTHCARE SPENDING, 2012–2030 (USD BILLION) 63
FIGURE 25 US: NUMBER OF DATA BREACHES (JANUARY 2009–MAY 2023) 69
FIGURE 26 DIRECT VS. INDIRECT DATA MONETIZATION 74
FIGURE 27 HEALTHCARE DATA MONETIZATION MARKET: SUPPLY CHAIN 79
FIGURE 28 HEALTHCARE DATA MONETIZATION ECOSYSTEM 81
FIGURE 29 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE DATA MONETIZATION SOLUTIONS, JANUARY 2015–MAY 2025 83
FIGURE 30 TOP APPLICANT COUNTRIES/JURISDICTIONS FOR PATENTS RELATED TO HEALTHCARE DATA MONETIZATION, JANUARY 2015–MAY 2025 84
FIGURE 31 HEALTHCARE DATA MONETIZATION MARKET: PORTER’S FIVE FORCES ANALYSIS 94
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 96
FIGURE 33 KEY BUYING CRITERIA, BY END USER 97
FIGURE 34 PRICING ANALYSIS: DATA MONETIZATION MARKET 102
FIGURE 35 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS 103
FIGURE 36 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET SNAPSHOT 142
FIGURE 37 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET SNAPSHOT 169
FIGURE 38 REVENUE ANALYSIS OF KEY MARKET PLAYERS, 2020–2024 205
FIGURE 39 HEALTHCARE DATA MONETIZATION MARKET: MARKET SHARE ANALYSIS, 2024 206
FIGURE 40 HEALTHCARE DATA MONETIZATION MARKET: COMPANY EVALUATION
MATRIX (KEY PLAYERS), 2024 209
FIGURE 41 HEALTHCARE DATA MONETIZATION MARKET: COMPANY FOOTPRINT 210
FIGURE 42 HEALTHCARE DATA MONETIZATION MARKET: COMPANY EVALUATION
MATRIX (STARTUPS/SMES), 2024 215
FIGURE 43 EV/EBITDA OF KEY VENDORS 218
FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS 218
FIGURE 45 HOSPITAL INFORMATION SYSTEMS MARKET: BRAND/SOFTWARE
COMPARATIVE ANALYSIS 219
FIGURE 46 ORACLE: COMPANY SNAPSHOT 223
FIGURE 47 MICROSOFT: COMPANY SNAPSHOT 231
FIGURE 48 GOOGLE: COMPANY SNAPSHOT 238
FIGURE 49 SALESFORCE, INC.: COMPANY SNAPSHOT 245
FIGURE 50 SAP SE: COMPANY SNAPSHOT 257
FIGURE 51 SNOWFLAKE INC.: COMPANY SNAPSHOT 268
FIGURE 52 INFOSYS LIMITED: COMPANY SNAPSHOT 277
FIGURE 53 ACCENTURE: COMPANY SNAPSHOT 283
FIGURE 54 DOMO, INC.: COMPANY SNAPSHOT 292
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11